Mirati Therapeutics, Inc.
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. The company is committed to transforming lives through science, with a focus on patient-centric solutions, scientific innovation, and responsible business practices. It operates worldwide, with a strong emphasis on research, diversity, and community support.
Industries
Nr. of Employees
large (251-1000)
Mirati Therapeutics, Inc.
Patents
Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer
US-12252493-B2
View Details
Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer
US-12252493-B2
View DetailsProducts
Therapeutic medicines portfolio across major disease areas
A portfolio of approved medicines and development-stage therapeutics for oncology, cardiovascular disease, immunological disorders and hematology.
Therapeutic medicines portfolio across major disease areas
A portfolio of approved medicines and development-stage therapeutics for oncology, cardiovascular disease, immunological disorders and hematology.
Services
Design and operational support for clinical studies and a public trial search/matching service for investigators and participants.
Online medical information services providing product and disease information to HCPs.
Financial assistance and support services to help eligible patients access prescribed therapies.
Funding programs and scholarships to support healthcare professional education and conference participation.
External partnering, licensing and collaboration activities to extend therapeutic pipelines and capabilities.
Design and operational support for clinical studies and a public trial search/matching service for investigators and participants.
Online medical information services providing product and disease information to HCPs.
Financial assistance and support services to help eligible patients access prescribed therapies.
Funding programs and scholarships to support healthcare professional education and conference participation.
External partnering, licensing and collaboration activities to extend therapeutic pipelines and capabilities.
Expertise Areas
- Clinical trial management
- Immuno-oncology
- Cell therapy / CAR-T
- Oncology research
Key Technologies
- Immuno-oncology platforms
- CAR-T and cell therapy technologies
- Radiopharmaceutical therapies
- Digital health applications (patient-facing)